Clark David J 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 8, 2018
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Common Stock
2017-12-29$4.00/sh+4,774$19,072→ 4,774 total - Award
Employee Stock Option (Right to Buy)
2018-03-06+108,633→ 108,633 totalExercise: $8.60Exp: 2028-03-05→ Common Stock (108,633 underlying)
Footnotes (3)
- [F1]Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018.